Mesenchymal stem cells (MSCs) are multipotent cells commonly derived from the bone marrow, adipose tissue and placenta. Human bone marrow derived MSCs migrate to a site of injury, release proinflammatory cytokines and modulate T-cell proliferation. At sites of injury, MSCs may well encounter bacterial pathogens most commonly the Gram positive pathogen Staphylococcus aureus. However, the precise molecular mechanism(s) of this interaction remain to be elucidated. In the present study we aim to show if a direct interaction occurs between S. aureus and bone marrow derived MSCs and identify if MSCRAMMs have a role in this interaction. We further aim to compare S. aureus interaction with cells that differentiate from MSCs, namely; osteoblasts, adipocytes and chondrocytes, since MSCs co-exist in the niche of these cells. Our results showed that S. aureus is able to interact with MSCs in the form of adhesion and invasion to the cells, and that this interaction is largely dependent on the expression of fibronecting-binding protein (FnBP) by S. aureus. We also showed that the same mechanism of interaction to osteoblasts, adipocytes and chondrocytes that are directly differentiated from the same MSCs. Finally, we have found that the presence of 10% FBS in the infection medium is essential as it helps in achieving the best specific bacterial-cell association with the least background association. The results reveals a mechanism of interaction between S. aureus and MSCs that could pave the way for therapeutic intervention that minimises the burden of infection in inflammatory diseases.
Introduction 1
Mesenchymal stem cells (MSCs) are a heterogeneous population of cells commonly derived 2 from bone marrow, adipose tissue and placenta (1). The major characteristics of MSCs, are 3 their fibroblast like morphology, their ability to adhere to plastic and their ability to 4 differentiate along the osteogenic, chondrogenic and adipogenic pathways. The mechanism Materials and Methods 46 47 Isolation and expansion of Mesenchymal stem cells 48 Bone marrow aspirates were collected into heparinised tubes to avoid samples clotting. 49 Subsequently, 1 ml of each aspirate was dispersed in T175 culture flasks containing 25 ml of 50 low glucose Dulbecco's Modified Eagle's Medium (DMEM) (Sigma, Dorset, UK), 51 supplemented with 10% (v/v) FBS, 1% penicillin/streptomycin, 1% (v/v) glutamax, and 10 52 ng/ml FGF-2. After XXX days, population purity and phenotype were assessed by flow 53 cytometry. Human MSCs at passage 4 were seeded into 96 well plates at a density of 5000 54 cells/cm 2 until confluence and used for differentiation or infection experiments as described 55 below.
56
Mesenchymal stem cell differentiation 57 MSCs differentiation was effected using aHuman Mesenchymal Stem Cell Functional 58 Identification Kit, (R&D Systems, Inc.) according to the manufacturer's instructions. 59 Following differentiation the resulting osteoblasts, adipocytes and chondrocytes were seeded 60 into 96 well plates and grown to confluency for subsequent infection experiments. in 5% CO2. In order to determine the effect of FBS, Human serum and plasma fibronectin on 80 bacterial adhesion, infection medium was supplemented with either 10% FBS, 10% heat 81 inactivated human serum (HuSer), or 400 µg/ml plasma fibronectin (Fn) . (comparable to the 82 Fn concentration in human plasma which is 300-400 µg/ml (26)) and low glucose DMEM with 83 10% decomplemented human serum (HuSer) . At the end of each infection assay unbound 84 bacterial cells were removed by washing each well 4 times with appropriate infection media. 85 Immunofluorecscence Microcopy 86 Cells were then fixed in 2% PFA (paraformaldehyde) overnight at 4°C. Wells were 87 subsequently washed with dH20 for 5 minutes and non-specific binding sites blocked for 1h at 88 room temperature (RT),with 3% bovine serum albumin (BSA)in PBS. . Bacteria were detected 89 using Rabbit anti-S. aureus polyclonal antibody (Abd Serotec; 2 µg/ ml in 1% BSA) or Mouse 90 anti-S. epidermidis (Thermo scientific; 3 µg/ ml in 1% BSA). MSC's were labelled with anti-91 vimentin monoclonal antibody (Sigma; 1 µg/ ml in 1% BSA). Primary antibodies were detected 92 using 1 µg/ ml of anti-rabbit Alexa Fluor 594 or anti-mouse Alexa Fluor 488 in 1%BSA as 93 appropriate (Invitrogen). All antibodies were incubated at room temperature for 1 hr, then wells 94 were washed 3 times for 5 minutes (PBS with 0.05% v/v Tween 20). Finally, 100 µl of 4',6-95 Diamidine-2-Phenylindole (DAPI; 1 µg/ ml in PBS) was added to each wells for 30 min to 96 stain nuclei. Plates were stored in PBS containing 0.05% sodium azide. Images were captured 97 using a Hamamatsu digital camera attached to an Olympus IX70 microscope via Image HCI 98 software.
99
Bacterial quantificationIn order to determine nuber of bacteria associated with each cell type, 100 following washing to remove unbound bacteria, well were incubated with with 1% Saponin 101 for 30min at 37 o C. Dilutions were cultured on MHA plates and viable colony forming units 102 (CFU) counted in order to determine the number of bacteria per well. In order to differentiate 103 invasive from associated bacteria prior to addition of saponin, well were incubated with
The results were comparable to that of osteoblasts regarding the adhesion capabilities of S. 141 aureus WT to adipocytes and the great reduction in adhesion with the use of ∆FnBPA/B mutant 142 bacteria which is restored again and to a higher degree with the use of S. aureus pFnBPA4 143 mutant as shown in Fig.3 
Adhesion of S. aureus to differentiated chondrocytes and the role of FnBP

147
The results shown in Fig.4 (A) , (B), and (C) confirmed that S. aureus WT was able to adhere 148 to chondrocytes and the absence of FnBP (with the use of ∆FnBPA/B mutant bacteria) greatly 149 affected the adhesion in a negative way, while the use of S. aureus pFnBPA4 mutant greatly 150 enhanced adhesion capability of S. aureus, even to a higher degree that WT strain. Also, S. MSCs which is statistically higher (p value ≤ 0.001) than that for S. aureus ∆FnBP (0.23%) 172 and S. epidermidis (0.32%), while S. aureus ∆FnBP p4A, a mutant strain expressing intact 173 FnBP type A have the highest association at 40.26%, which is statistically higher than WT 174 strain (p value ≤ 0.001). These results confirm the ability of S. aureus to associate with MSCs 175 and that FnBP plays a major role in this association, while the increase in association with the 176 use ∆FnBP p4A confirm the role of FnBP in the association and that Type A FnBP has a higher 177 significance.
178
After confirming bacterial association with MSCs, extracellular bacteria were killed by 179 gentamicin in order to prove the intracellular presence of S. aureus in the MSCs. The results 180 stated that for S. aureus WT, 1.59% of the associated bacteria invaded MSCs, which is higher, 181 with a high statistical significance (p value ≤ 0.001), than that for S. aureus ∆FnBP (0.47%) 182 and S. epidermidis (0.55%) as shown in Fig osteoblasts which is statistically higher (p value ≤ 0.001) than that for S. aureus ∆FnBP (1.6%) 191 and S. epidermidis (2.82%), while S. aureus ∆FnBP p4A, a mutant strain expressing intact 192 FnBP type A have the highest association at 20.76%, which is statistically higher than WT 193 strain (p value ≤ 0.05). These results confirm the ability of S. aureus to associate with 194 osteoblasts and that FnBP plays a major role in this association, while the increase in 195 association with the use ∆FnBP p4A confirm the role of FnBP in the association and that Type 196 A FnBP has a higher significance.
197
After confirming bacterial association with osteoblasts, extracellular bacteria were killed by 198 gentamicin in order to prove the intracellular presence of S. aureus in the osteoblasts. The 199 results stated that for S. aureus WT, 1.36% of the associated bacteria invaded osteoblasts, 200 which is higher, with a high statistical significance (p value ≤ 0.001), than that for S. aureus 201 ∆FnBP (0.18%) and S. epidermidis (0.38%) as shown in Fig. 9 , while ∆FnBP p4A show higher 202 invasion (1.60%) than other strains, but with no statistical difference from S. aureus WT (p 203 value ≥ 0.5) as shown in Fig. 9 . These results show the ability of S. aureus to invade osteoblasts 204 and that the invasion is greatly reduced in the absence of FnBP, while the use of ∆FnBP p4A, 205 a mutant strain expressing intact FnBP type A, greatly enhance the invasion to a degree 206 comparable to that of the wild type strain. Adipocytes which is statistically higher (p value ≤ 0.001) than that for S. aureus ∆FnBP 210 (1.44%) and S. epidermidis (0.57%), while S. aureus ∆FnBP p4A, a mutant strain expressing 211 intact FnBP type A have the highest association at 26.08%, which is statistically higher than 212 WT strain (p value ≤ 0.05). These results confirm the ability of S. aureus to associate with 213 Adipocytes and that FnBP plays a major role in this association, while the increase in 214 association with the use ∆FnBP p4A confirm the role of FnBP in the association and that Type 215 A FnBP has a higher significance.
216
After confirming bacterial association with Adipocytes, extracellular bacteria were killed by 217 gentamicin in order to prove the intracellular presence of S. aureus in the Adipocytes. The 218 results stated that for S. aureus WT, 1.82% of the associated bacteria invaded Adipocytes, 219 which is higher than that for S. aureus ∆FnBP (0.57%) and S. epidermidis (0.32%) as shown 220 in Fig. 11 with a statistical significance (p value ≤ 0.001 and ≤ 0.001 respectively). The 221 bacterial invasion increase with the use of bacterial strain ∆FnBP p4A at 1.23% , but there was 222 no statistical significance from the invasion for S. aureus WT and ∆FnBP (p value > 0.5) as Chondrocytes which is statistically higher (p value ≤ 0.001) than that for S. aureus ∆FnBP 231 (0.83%) and S. epidermidis (0.54%), while S. aureus ∆FnBP p4A, a mutant strain expressing 232 intact FnBP type A have the highest association at 10.43%, which is statistically higher than 233 WT strain (p value ≤ 0.01). These results confirm the ability of S. aureus to associate with 234 Chondrocytes and that FnBP plays a major role in this association, while the increase in 235 association with the use ∆FnBP p4A confirm the role of FnBP in the association and that Type 236 A FnBP has a higher significance.
237
After confirming bacterial association with Chondrocytes, extracellular bacteria were killed by 238 gentamicin in order to prove the intracellular presence of S. aureus in the Chondrocytes. The 239 results stated that for S. aureus WT, 2.65% of the associated bacteria invaded Chondrocytes, 240 which is higher, with a high statistical significance (p value ≤ 0.001), than that for S. aureus 241 ∆FnBP (0.50%) and S. epidermidis (0.61%) as shown in Fig. 13 , while ∆FnBP p4A show 242 higher invasion (1.98%) than other strains with no statistical difference from S. aureus WT (p 243 value >0.5) as shown in Fig. 13 . These results show the ability of S. aureus to invade 244 Chondrocytes and that the invasion is greatly reduced in the absence of FnBP, while the use of 
254
The first aim for the experiments conducted in this study was to confirm the interaction between 255 bone marrow MSCs and S. aureus, determining the underlying mechanism and ability of 256 bacteria to invade these cells and survive intracellulary. Then we tried to confirm that this 257 interaction and subsequent invasion and intracellular survival of bacteria, extends to involve 258 the cells which are directly differentiated from these MSCs, namely osteoblasts, adipocytes 259 and chondrocytes.
260
Infection assay was done using MOI 100 as preliminary studies (comparing different MOIs) 261 showed that at this MOI, there is a uniform distribution of the bacterial strain over the cell shown in immunofluorescence adhesion assays in Figures 1, 2 , 3, and 4. We found that FnBP 266 plays a major role in this interaction as the adherent bacterial number was greatly reduced when 267 using S. aureus ∆FnBP, a mutant lacking the expression of FnBP A/B, and then the percentage 268 of adherent bacteria increase again, more than the wild type strain, when using bacterial strain 269 ∆FnBP p4A that is ∆FnBP mutant strain supplemented with plasmid expressing intact FnBP 270 type A as shown in Figures 1, 2, 3 while this was not the case in the presence of serum free medium with high, non-specific 282 adhesion similar to that of the WT strain. 283 We have noticed that there is very low specific bacterial adhesion to MSCs in the presence of 284 serum free medium, as stated above, and this may prove the release of cellular fibronectin by 285 MSCs which is used as a bridge for the adhesion process. Also, we have found that the addition 
294
The uptake of S. aureus by osteoblasts, and many other cell types necessitates the expression 295 of FnBPs on the surface of the bacterium (6, 33, 34) . These proteins belong to MSCRAMMs 296 (microbial surface components recognising adhesive matrix molecules), which bind an array 297 of extracellular matrix proteins such as collagen, elastin, fibrinogen, fibronectin, and bone sialo 298 protein (35). The invasion of host cells by mutant bacterial strains lacking the two FnBPs, 299 FnBPA and FnBPB were greatly reduced (33, 34) . During the adhesion and invasion processes, 300 S. aureus attaches to fibronectin via FnBPs expressed on their surface, and extracellular matrix 301 fibronectin functions as a bridging molecule to the integrin α5β1 that serves as a ''phagocytic'' 302 receptor leading to changes in the cytoskeleton of the cell and uptake of bacteria (9, 36).
303
Our results in the quantification association assay (Figures 6, 7 of results) showed that this 304 specific binding protein plays a significant role in the binding of S. aureus to bmMSC. The two 305 strains expressing this protein (WT, and ∆FnPB pA4) were able to adhere to and invade 306 bmMSCs, while strains missing the binding protein failed to do that. ∆FnPB pA4, nevertheless, 307 exhibited higher adherence followed by higher invasion results as paralleled to WT strain.
308
Those results were consistent with other studies, as S. aureus was able to invade human 309 Wharton's jelly MSCs and adipose MSCs and that only small number of adherent bacteria were 310 able to invade MSCs (5, 28).
311
The ability of S. aureus to interact with osteoblasts was extensively studied, mostly using cell 312 lines. In this study we tested the ability of S. aureus to adhere and invade differentiated human 313 osteoblasts (from bmMSCs) and we found that FnBP plays significant role in the interaction 314 of S. aureus with osteoblasts ( Fig. 8 and 9 ). The two strains expressing this protein (WT, and 315 ∆FnPB pA4) was able to adhere to and invade osteoblasts, while strains missing the binding 316 protein failed to do that. ∆FnPB pA4, nevertheless, exhibited higher adherence followed by 317 nearly similar invasion results as paralleled to WT strain. These results are comparable to that 318 of other studies (33, (37) (38) (39) (40) . 319 We also found that FnBP plays the same role in the interaction of S. aureus with differentiated 320 adipocytes and chondrocytes (Figures 10, 11, 12 and 13 of results) . The two strains expressing 321 this protein (WT, and ∆FnPB pA4) was able to adhere to and invade these cells, while strains 322 missing the binding protein failed to do that. Although, ∆FnPB pA4 does not shown 323 significantly higher results than WT strain, as was the case with MSCs and to a less degree 324 osteoblasts. A study by Hanses et al., 2011 confirmed the ability of S. aureus to invade 325 adipocyte-like differentiated 3T3-L1 cells, but without studying the underlying mechanism for 326 this invasion (41).
327
Conclusion
328
Our results showed that S. aureus is able to interact with MSCs in the form of adhesion and 329 invasion to the cells, and that this interaction is largely dependent on the expression of FnBP 330 by S. aureus. We also showed that the same mechanism of interaction take place in case of S. 331 aureus interaction with osteoblasts, adipocytes and chondrocytes that are directly differentiated 332 from the same MSCs. Finally, we have found that the presence of 10% FBS in the infection 333 medium is essential as it helps in achieving the best specific bacterial-cell association with the 334 least background association. 
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Figure 6
Association assay for MSCs with 4 bacterial strains. Conflunt MSCs in 96 well plate were infected with 4 bacterial strains at MOI 100 for 3 hr, then washing and serial dilution was done followed by inoculation of dilution factors in MHA plates and CFU count done after 24 hr. The data are from three independent experiments of three patients. WT=wild type, DFnBP=mutant lacking the expression of fibronectin binding protein A/B, DFnBP p4A=mutant supplemented with plasmid expressing intact fibronectin binding protein type A. *** = P < 0.001 , ns = P > 0.05 Figure 7 Invasion assay for MSCs with 4 bacterial strains. Conflunt MSCs in 96 well plate were infected with 4 bacterial strains at MOI 100 for 3 hr, then washing and the plate incubated with gentamycin for 90 min to kill extracellular bacteria, then washing and serial dilution was done followed by inoculation of dilution factors in MHA plates and CFU count done after 24 hr. The data are from three independent experiments of three patients. WT=wild type, DFnBP=mutant lacking the expression of fibronectin binding protein A/B, DFnBP p4A=mutant supplemented with plasmid expressing intact fibronectin binding protein type A. *** = P < 0.001 , * = P < 0.05 Figure 8 Association assay for osteoblasts with 4 bacterial strains. Conflunt osteoblasts in 96 well plate were infected with 4 bacterial strains at MOI 100 for 3 hr, then washing and serial dilution was done followed by inoculation of dilution factors in MHA plates and CFU count done after 24 hr. The data are from three independent experiments of three patients. WT=wild type, DFnBP=mutant lacking the expression of fibronectin binding protein A/B, DFnBP p4A=mutant supplemented with plasmid expressing intact fibronectin binding protein type A. *** = P < 0.001, * = P < 0.05, ns = P > 0.05 Figure 9 Invasion assay for Osteoblasts with 4 bacterial strains. Conflunt Osteoblasts in 96 well plate were infected with 4 bacterial strains at MOI 100 for 3 hr, then washing and the plate incubated with gentamycin for 90 min to kill extracellular bacteria, then washing and serial dilution was done followed by inoculation of dilution factors in MHA plates and CFU count done after 24 hr. The data are from three independent experiments of three patients. WT=wild type, DFnBP=mutant lacking the expression of fibronectin binding protein A/B, DFnBP p4A=mutant supplemented with plasmid expressing intact fibronectin binding protein type A. *** = P < 0.001, ** = P < 0.01, ns = P > 0.05 Figure 10 Association assay for adipocytes with 4 bacterial strains. Conflunt adipocytes in 96 well plate were infected with 4 bacterial strains at MOI 100 for 3 hr, then washing and serial dilution was done followed by inoculation of dilution factors in MHA plates and CFU count done after 24 hr. The data are from three independent experiments of three patients. WT=wild type, DFnBP=mutant lacking the expression of fibronectin binding protein A/B, DFnBP p4A=mutant supplemented with plasmid expressing intact fibronectin binding protein type A. *** = P < 0.001, ** = P < 0.01, *= P £ 0.05, ns = P > 0.05 Figure 11 Invasion assay for Adipocytes with 4 bacterial strains. Conflunt Adipocytes in 96 well plate were infected with 4 bacterial strains at MOI 100 for 3 hr, then washing and the plate incubated with gentamycin for 90 min to kill extracellular bacteria, then washing and serial dilution was done followed by inoculation of dilution factors in MHA plates and CFU count done after 24 hr. The data are from three independent experiments of three patients. WT=wild type, DFnBP=mutant lacking the expression of fibronectin binding protein A/B, DFnBP p4A=mutant supplemented with plasmid expressing intact fibronectin binding protein type A. *** = P < 0.001, ** = P < 0.01, *= P < 0.05, ns = P > 0.05 Figure 12 Association assay for chondrocytes with 4 bacterial strains. Conflunt chondrocytes in 96 well plate were infected with 4 bacterial strains at MOI 100 for 3 hr, then washing and serial dilution was done followed by inoculation of dilution factors in MHA plates and CFU count done after 24 hr. The data are from three independent experiments of three patients. WT=wild type, DFnBP=mutant lacking the expression of fibronectin binding protein A/B, DFnBP p4A=mutant supplemented with plasmid expressing intact fibronectin binding protein type A. *** = P < 0.001, ** = P < 0.01, ns = P > 0.05 Figure 13 Invasion assay for Chondrocytes with 4 bacterial strains. Conflunt chondrocytes in 96 well plate were infected with 4 bacterial strains at MOI 100 for 3 hr, then washing and the plate incubated with gentamycin for 90 min to kill extracellular bacteria, then washing and serial dilution was done followed by inoculation of dilution factors in MHA plates and CFU count done after 24 hr. The data are from three independent experiments of three patients. WT=wild type, DFnBP=mutant lacking the expression of fibronectin binding protein A/B, DFnBP p4A=mutant supplemented with plasmid expressing intact fibronectin binding protein type A. *** = P < 0.001, ** = P < 0.01, ns = P > 0.05 
